share_log
Reuters ·  May 6 07:04
Stoke Therapeutics Inc - as of March 31, 2024, Company Had $178.6 Mln in Cash and Cash Equivalents
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment